* Co-Diagnostics Inc CODX.OQ reported quarterly adjusted
earnings of 8 cents per share for the quarter ended in June.
The mean expectation of three analysts for the quarter was
for earnings of 10 cents per share.
* Revenue fell 81.6% to $5.02 million from a year ago;
analysts
expected $20.50 million.
* Co-Diagnostics Inc's reported EPS for the quarter was 8
cents.
* The mean earnings estimate of analysts had fallen by
about 21.6%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Co-Diagnostics Inc shares had risen by 18.0% this
quarter and
lost 25.9% so far this year.
* The company reported a quarterly loss of $2.69 million.
* Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $14.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 11
at 09:01 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 0.10 0.08 Missed
Mar. 31 2022 0.17 0.34 Beat
Dec. 31 2021 0.12 0.25 Beat
Sep. 30 2021 0.21 0.38 Beat